BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17223160)

  • 21. Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.
    Fisher SP; Davidson K; Kulla A; Sugden D
    J Pineal Res; 2008 Sep; 45(2):125-32. PubMed ID: 18298466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward the definition of stereochemical requirements for MT2-selective antagonists and partial agonists by studying 4-phenyl-2-propionamidotetralin derivatives.
    Bedini A; Lucarini S; Spadoni G; Tarzia G; Scaglione F; Dugnani S; Pannacci M; Lucini V; Carmi C; Pala D; Rivara S; Mor M
    J Med Chem; 2011 Dec; 54(24):8362-72. PubMed ID: 22047556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.
    Mathé-Allainmat M; Gaudy F; Sicsic S; Dangy-Caye AL; Shen S; Brémont B; Benatalah Z; Langlois M; Renard P; Delagrange P
    J Med Chem; 1996 Aug; 39(16):3089-95. PubMed ID: 8759629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin-enhanced hyperactivation of hamster sperm.
    Fujinoki M
    Reproduction; 2008 Nov; 136(5):533-41. PubMed ID: 18715981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards the development of mixed MT(1)-agonist/MT(2)-antagonist melatonin receptor ligands.
    Spadoni G; Bedini A; Guidi T; Tarzia G; Lucini V; Pannacci M; Fraschini F
    ChemMedChem; 2006 Oct; 1(10):1099-105. PubMed ID: 16955531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzocyclobutane, benzocycloheptane and heptene derivatives as melatonin agonists and antagonists.
    Tsotinis A; Afroudakis PA; Garratt PJ; Bocianowska-Zbrog A; Sugden D
    ChemMedChem; 2014 Oct; 9(10):2238-43. PubMed ID: 25044938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular cloning and pharmacological characterization of rat melatonin MT1 and MT2 receptors.
    Audinot V; Bonnaud A; Grandcolas L; Rodriguez M; Nagel N; Galizzi JP; Balik A; Messager S; Hazlerigg DG; Barrett P; Delagrange P; Boutin JA
    Biochem Pharmacol; 2008 May; 75(10):2007-19. PubMed ID: 18384758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells.
    Imbesi M; Uz T; Manev H
    Neuroscience; 2008 Sep; 155(4):1160-4. PubMed ID: 18664376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and pharmacological effects of structurally simple ligands for MT(1) and MT(2) melatonin receptors.
    Carocci A; Catalano A; Lovece A; Lentini G; Duranti A; Lucini V; Pannacci M; Scaglione F; Franchini C
    Bioorg Med Chem; 2010 Sep; 18(17):6496-511. PubMed ID: 20674373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands.
    Rivara S; Vacondio F; Fioni A; Silva C; Carmi C; Mor M; Lucini V; Pannacci M; Caronno A; Scaglione F; Gobbi G; Spadoni G; Bedini A; Orlando P; Lucarini S; Tarzia G
    ChemMedChem; 2009 Oct; 4(10):1746-55. PubMed ID: 19728346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of 4-arylpiperidinyl amide and N-arylpiperdin-3-yl-cyclopropane carboxamide derivatives as novel melatonin receptor ligands.
    Li G; Zhou H; Jiang Y; Keim H; Topiol SW; Poda SB; Ren Y; Chandrasena G; Doller D
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1236-42. PubMed ID: 21237644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput screening assay for new ligands at human melatonin receptors.
    Yan JH; Su HR; Boutin JA; Renard MP; Wang MW
    Acta Pharmacol Sin; 2008 Dec; 29(12):1515-21. PubMed ID: 19026172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and pharmacological evaluation of a novel series of 2-(phenylthio)benzo[b]thiophenes as selective MT2 receptor ligands.
    Mésangeau C; Fraise M; Delagrange P; Caignard DH; Boutin JA; Berthelot P; Yous S
    Eur J Med Chem; 2011 May; 46(5):1835-40. PubMed ID: 21392858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands.
    Attia MI; Witt-Enderby PA; Julius J
    Bioorg Med Chem; 2008 Aug; 16(16):7654-61. PubMed ID: 18657980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (R)-2-(4-Phenylbutyl)dihydrobenzofuran derivatives as melatoninergic agents.
    Sun LQ; Takaki K; Chen J; Bertenshaw S; Iben L; Mahle CD; Ryan E; Wu D; Gao Q; Xu C
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1345-9. PubMed ID: 15713384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of new N-OMe fluoro-indole melatoninergics.
    Tsotinis A; Gourgourinis J; Eleutheriades A; Davidson K; Sugden D
    Med Chem; 2007 Nov; 3(6):561-71. PubMed ID: 18045206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New melatonin (MT1/MT2) ligands: design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives.
    Landagaray E; Ettaoussi M; Leclerc V; Traoré B; Perez V; Nosjean O; Boutin JA; Caignard DH; Delagrange P; Berthelot P; Yous S
    Bioorg Med Chem; 2014 Feb; 22(3):986-96. PubMed ID: 24417958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: design, synthesis, and pharmacological characterization of a novel class of highly potent MT₂-selective agonists.
    Koike T; Hoashi Y; Takai T; Nakayama M; Yukuhiro N; Ishikawa T; Hirai K; Uchikawa O
    J Med Chem; 2011 May; 54(9):3436-44. PubMed ID: 21473625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An endogenous 5-HT(7) receptor mediates pigment granule dispersion in Xenopus laevis melanophores.
    Teh MT; Sugden D
    Br J Pharmacol; 2001 Apr; 132(8):1799-808. PubMed ID: 11309252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bivalent ligand approach on N-{2-[(3-methoxyphenyl)methylamino]ethyl}acetamide: synthesis, binding affinity and intrinsic activity for MT(1) and MT(2) melatonin receptors.
    Spadoni G; Bedini A; Orlando P; Lucarini S; Tarzia G; Mor M; Rivara S; Lucini V; Pannacci M; Scaglione F
    Bioorg Med Chem; 2011 Aug; 19(16):4910-6. PubMed ID: 21775151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.